title: Economics of diabetes-cost impact of not treating diabetes early and intensively.
abstract: The prevalence of type 2 diabetes mellitus (DM) has become epidemic in Western society. The direct and indirect medical costs of caring for patients with type 2 DM and its complications are staggering and will continue to grow with the increasing incidence of the disease. Studies show that preventive treatment, such as lifestyle changes and potentially pharmacologic therapy, may reduce the risk for diabetes and its complications, potentially reducing the costs of the disease.
authors.affiliation: Division of Nutrition and Chronic Disease, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808, USA. cefaluwt@pbrc.edu
authors.forename: William
authors.initials: W
authors.lastname: Cefalu
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000191:economics* / Q000517:prevention & control; D017048:Health Care Costs; D006801:Humans; D007004:Hypoglycemic Agents / Q000191:economics / Q000627:therapeutic use; D008019:Life Style; D012307:Risk Factors; D014481:United States
chemical_list: D007004:Hypoglycemic Agents